Stories
Prime takes third in the 2020 Best Places to Work in New Mexico
Prime Therapeutics was named an employer of choice, noted for excellent morale, engagement and retention
August 28, 2020Finalist scores were revealed at a virtual awards ceremony on Aug. 20. Winning companies were recognized for creating positive work environments, and for promoting New Mexico and its area employers. Read more about the Best Places to Work winners in the online edition of Albuquerque Business First and more about the survey and selection process here.
Survey comments revealed the coronavirus pandemic and its unique challenges as a common theme this year. Albuquerque Business First noted that more than 70 percent of this year’s finalists said it was important that their company helped them balance working from home with their personal obligations.
When all of Prime moved to become remote in March, Albuquerque employees turned this challenge into an advantage. “Working remotely supports a flexible work-life balance. That has helped keep our staff happy and motivated,” says Dan White, director, operations. “I’m particularly proud that our productivity and quality have continued to improve under the new working conditions,” he adds.
This success contributed to Prime’s decision to permanently move to a remote working environment in Albuquerque. Although the workforce will be more geographically dispersed, Prime’s commitment to Albuquerque will continue. “Even with our employees working from home, we will continue to invest in the community and in local programs important to our employees,” says Maria Schoneman, senior HR business partner.
Prime’s dedicated workforce in Albuquerque – and across Prime – has risen to the challenges presented by the pandemic. “Despite everything we’ve faced this year, winning this award illustrates how connected employees continue to feel to Prime, and to our mission to help people get the medicine they need to feel better and live well,” Dan adds.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion